Dr Massimiliano di Pietro

Dr di Pietro qualified from Federico II University of Naples, Italy and obtained an MD at the Institute of Molecular Cancer Research (University of Zurich, Switzerland). He is Principal Research Associate at the Early Cancer Institute, University of Cambridge and Consultant Gastroenterologist at Addenbrooke’s Hospital, where he provides regional referral for endoscopic treatment of pre-cancerous and early malignant conditions of the upper GI tract, including endoscopic mucosal resection, endoscopic submucosal dissection and Radiofrequency Ablation. Dr di Pietro has a research interest in oesophageal and gastric pre-malignant and early malignant pathologies. In particular, his research focusses on advanced endoscopic imaging, key performance indicators in UGI endoscopy and molecular biomarkers for cancer risk stratification. He has led the current BSG and NICE guidelines for management of Barrett’s oesophagus and co-authored ESGE, BSG guidelines for management of pre-malignant stomach and the International Guidelines for the management of Hereditary Diffuse Gastric Cancer. He is lead on several prospective trials for the early detection of upper GI cancer, including BEST4 surveillance trial (Capsule sponge for surveillance of Barrett’s oesophagus) and PROSPERO (prospective study to determine quality indicators in upper GI endoscopy). He has received the 2022 BSG Hopkins Endoscopy Award in recognition to his contribution to research in endoscopy.